Form 4: TD SYNNEX Director Sells Shares Under 10b5-1 Plan

TD SYNNEX Corp. Director Richard T. Hume sold a significant number of common shares through a pre-arranged trading plan, as disclosed in a Form 4 filing.

Summary

• Richard T. Hume, a Director at TD SYNNEX Corp. (SNX), executed a series of sales of common stock on May 5, 2026.
• These transactions were conducted under a Rule 10b5-1 trading plan established on February 2, 2026.
• The sales involved a total of 5,321 shares across multiple transactions, with weighted average sale prices ranging from $230.72 to $234.44.
• Following these sales, Mr. Hume beneficially owns 33,537 shares of TD SYNNEX Corp. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as the sales were conducted under a pre-established 10b5-1 plan, indicating a planned transaction rather than a reaction to new information.

Negatives

• Director Richard T. Hume sold a total of 5,321 shares of TD SYNNEX Corp. common stock.
• The sales occurred on May 5, 2026, with weighted average prices ranging from $230.72 to $234.44.

Future Outlook

No specific future outlook or guidance is provided in this filing, which solely reports on past transactions.

Industry Context

StockSavvy.ai notes that insider sales, particularly when executed under a Rule 10b5-1 plan, are common and often reflect pre-planned diversification or liquidity strategies rather than a negative view of the company's prospects. However, significant sales by directors can sometimes be interpreted by the market as a signal, depending on the volume and context.

Stakeholder Impact

• Shareholders: The sale of shares by a director may be perceived by some shareholders as a negative signal, although the use of a 10b5-1 plan mitigates this concern by indicating a pre-planned strategy.
• Company Management: The transaction is a standard disclosure for a director and does not directly impact other management personnel.

Key Dates

Keywords

TD SYNNEX Corp, SNX, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Director Sale, Beneficial Ownership